EIP
REGN icon

Easterly Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Easterly Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Buy
5,197
+3,444
+196% +$2.34M 0.16% 119
2026
Q1 		$1.32M Sell
1,753
-16
-0.9% -$12.2K 0.1% 104
2025
Q4 		$1.37M Buy
1,769
+31
+2% +$21.1K 0.08% 139
2025
Q3 		$977K Buy
+1,738
New +$983K 0.07% 153

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Easterly Investment Partners's REGN Position: Q2 2026 in Review

Easterly Investment Partners increased its Regeneron Pharmaceuticals (REGN) stake by 196% in Q2 2026, buying an estimated $2.34M and bringing the position to 5,197 shares worth $3.24M. The position accounts for 0.16% of the portfolio, ranked #119.

Easterly Investment Partners first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Easterly Investment Partners held 5,197 shares of Regeneron Pharmaceuticals worth $3.24M as of Q2 2026.
  • Easterly Investment Partners bought 3,444 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.34M.
  • Regeneron Pharmaceuticals made up 0.16% of Easterly Investment Partners's portfolio in Q2 2026, its #119 holding.
  • Easterly Investment Partners first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Easterly Investment Partners's 13F filing for Q2 2026, filed 23 Jul 2026.